Clinical Trial Update: Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating safety and immunogenicity of 10-valent and 13-valent pneumococcal conjugate vaccines in Papua New Guinean children; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteraemia
• Meningitis
• Otitis Media
• Pneumonia
• Sepsis

Drugs mentioned

• Prevnar 13 (pneumococcal conjugate vaccine)
• Synflorix (10-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Papua New Guinea Institute of Medical Research | Conditions: Pneumonia, Meningitis | Phase 3 | Status: UNKNOWN